American Extractions runs Google Ads pointing to a dedicated subdomain (separate from the main domain to avoid THC/CBD regulatory issues). As of October 2025, the campaigns show less than 10% impression share, with losses attributed primarily to rank rather than budget. The root cause is the subdomain's near-zero Domain Authority (DA), which suppresses Quality Score and ad rank.
This article documents the diagnosis, the planned remediation, and the broader principle at play.
Google's ad auction evaluates three core Quality Score factors:
Because American Extractions' ads point to a subdomain with no established DA, Google deprioritizes the ads in the auction regardless of bid. The result is a vicious cycle: low rank → low impressions → low CTR data → continued low rank.
Sending ads to the main domain (americanextractions.com) is not viable because the main site contains THC/CBD content, which creates regulatory risk with Google Ads policies.
Current tracking gaps identified during the October 27 call:
| Goal | Status | Action |
|---|---|---|
| Contact form fills | ✅ Active | Keep |
| Calls from ad extension | ✅ Active | Keep |
| Calls from landing page | ❌ Missing | Add |
| "Get directions" | ⚠️ Irrelevant | Remove |
Gilbert (ads manager) is responsible for implementing these changes. See [1] for contact details.
Increasing budget alone will not resolve the impression share problem if rank losses persist — DA remediation is the higher-leverage fix.
A subdomain with no Domain Authority will underperform in Google Ads regardless of bid or budget, because Quality Score is partially determined by the destination domain's perceived trustworthiness.
This pattern applies to any client where ads must point to a subdomain or microsites isolated from the main domain (common in regulated industries: cannabis, supplements, financial services). The options are:
For American Extractions, option 1 is the chosen path given the regulatory constraints.